Neurotoxicity of FIV and FIV envelope protein in feline cortical cultures

被引:17
作者
Bragg, DC
Meeker, RB
Duff, BA
English, RV
Tompkins, MB
机构
[1] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA
[3] N Carolina State Univ, Coll Vet Med, Dept Microbiol Parasitol & Pathol, Raleigh, NC 27606 USA
关键词
feline immunodeficiency virus; gp120; neurotoxicity; glutamate;
D O I
10.1016/S0006-8993(98)01177-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neurotoxic effects of the feline immunodeficiency virus (FIV) and FIV envelope proteins were measured in primary cultures of feline cortical neurons. Envelope protein from the FIV-PPR strain promoted neuronal swelling and death, whereas envelope protein from the FIV-34TF10 isolate produced intermediate or negligible toxicity. No effect was observed in control cultures treated with envelope protein from the Epstein-Barr virus. A concentration-effect curve showed that FIV-PPR protein produced maximal toxicity at 200 pM protein and decreased toxicity at higher concentrations, which is consistent with previous reports of the HIV-1 surface glycoprotein, gp120. These effects required the presence of low concentrations of glutamate. Using the natural host cells as targets, the effects of envelope protein and infectious virions were directly compared. All of the toxic activity could be attributed to non-infectious interactions between the viral envelope and target cells. Addition of 1 mu M tetrodotoxin failed to block the effects of FIV-PPR in the presence of 20 mu M glutamate. Toxicity would appear to involve two steps in which the envelope protein first sensitizes neurons through non-synaptic interactions (TTX insensitive) thereby setting the stage for enhanced synaptic activation via glutamate receptors (TTX sensitive). (C) 1999 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 52 条
[1]   Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry [J].
Bagasra, O ;
Lavi, E ;
Bobroski, L ;
Khalili, K ;
Pestaner, JP ;
Tawadros, R ;
Pomerantz, RJ .
AIDS, 1996, 10 (06) :573-585
[2]   FELINE IMMUNODEFICIENCY VIRUS - AN INTERESTING MODEL FOR AIDS STUDIES AND AN IMPORTANT CAT PATHOGEN [J].
BENDINELLI, M ;
PISTELLO, M ;
LOMBARDI, S ;
POLI, A ;
GARZELLI, C ;
MATTEUCCI, D ;
CECCHERININELLI, L ;
MALVALDI, G ;
TOZZINI, F .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (01) :87-112
[3]   NEURONAL CELL KILLING BY THE ENVELOPE PROTEIN OF HIV AND ITS PREVENTION BY VASOACTIVE INTESTINAL PEPTIDE [J].
BRENNEMAN, DE ;
WESTBROOK, GL ;
FITZGERALD, SP ;
ENNIST, DL ;
ELKINS, KL ;
RUFF, MR ;
PERT, CB .
NATURE, 1988, 335 (6191) :639-642
[4]   LENTIVIRAL INFECTION, IMMUNE-RESPONSE PEPTIDES AND SLEEP [J].
DARKO, DF ;
MITLER, MM ;
HENRIKSEN, SJ .
ADVANCES IN NEUROIMMUNOLOGY, 1995, 5 (01) :57-77
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COAT PROTEIN NEUROTOXICITY MEDIATED BY NITRIC-OXIDE IN PRIMARY CORTICAL CULTURES [J].
DAWSON, VL ;
DAWSON, TM ;
UHL, GR ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3256-3259
[6]   DIFFERENT PATTERNS OF NEUROPATHOLOGICAL DISEASE IN RHESUS-MONKEYS INFECTED BY SIMIAN IMMUNODEFICIENCY VIRUS, AND THEIR RELATION TO THE HUMORAL IMMUNE-RESPONSE [J].
DEAN, AF ;
MONTGOMERY, M ;
BASKERVILLE, A ;
COOK, RW ;
CRANAGE, MP ;
SHARPE, SA ;
DENNIS, MJ ;
LUTHERT, PJ ;
HOU, ST ;
LANTOS, PL .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1993, 19 (04) :336-345
[7]   TETRODOTOXIN BLOCKS HIV COAT PROTEIN (GP120) TOXICITY IN PRIMARY NEURONAL CULTURES [J].
DIOP, AG ;
LESORT, M ;
ESCLAIRE, F ;
SINDOU, P ;
COURATIER, P ;
HUGON, J .
NEUROSCIENCE LETTERS, 1994, 165 (1-2) :187-190
[8]   FELINE IMMUNODEFICIENCY VIRUS NEUROTROPISM - EVIDENCE THAT ASTROCYTES AND MICROGLIA ARE THE PRIMARY TARGET-CELLS [J].
DOW, SW ;
DREITZ, MJ ;
HOOVER, EA .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 35 (1-2) :23-35
[9]  
Epstein Leon G., 1997, P59
[10]   NEURONAL LOSS IN SYMPTOM-FREE HIV-INFECTION [J].
EVERALL, I ;
GRAY, F ;
BARNES, H ;
DURIGON, M ;
LUTHERT, P ;
LANTOS, P .
LANCET, 1992, 340 (8832) :1413-1413